Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

22,106 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Adverse events and oncologic outcomes with combination lenvatinib and pembrolizumab for the treatment of recurrent endometrial cancer.
Zammarrelli WA 3rd, Ma W, Espino K, Gordhandas S, Yeoshoua E, Ehmann S, Zhou Q, Iasonos A, Abu-Rustum NR, Aghajanian C, Green AK, Rubinstein MM, Makker V. Zammarrelli WA 3rd, et al. Among authors: zhou q. Gynecol Oncol. 2023 Nov;178:27-35. doi: 10.1016/j.ygyno.2023.09.010. Epub 2023 Sep 23. Gynecol Oncol. 2023. PMID: 37748268 Free PMC article.
Treatment patterns of FIGO Stage IB2 cervical cancer: a single-institution experience of radical hysterectomy with individualized postoperative therapy and definitive radiation therapy.
Zivanovic O, Alektiar KM, Sonoda Y, Zhou Q, Iasonos A, Tew WP, Diaz JP, Chi DS, Barakat RR, Abu-Rustum NR. Zivanovic O, et al. Among authors: zhou q. Gynecol Oncol. 2008 Nov;111(2):265-70. doi: 10.1016/j.ygyno.2008.07.050. Epub 2008 Sep 6. Gynecol Oncol. 2008. PMID: 18774596 Free PMC article.
Stage-specific outcomes of patients with uterine leiomyosarcoma: a comparison of the international Federation of gynecology and obstetrics and american joint committee on cancer staging systems.
Zivanovic O, Leitao MM, Iasonos A, Jacks LM, Zhou Q, Abu-Rustum NR, Soslow RA, Juretzka MM, Chi DS, Barakat RR, Brennan MF, Hensley ML. Zivanovic O, et al. Among authors: zhou q. J Clin Oncol. 2009 Apr 20;27(12):2066-72. doi: 10.1200/JCO.2008.19.8366. Epub 2009 Mar 2. J Clin Oncol. 2009. PMID: 19255317 Free PMC article.
Treatment of advanced uterine leiomyosarcoma with aromatase inhibitors.
O'Cearbhaill R, Zhou Q, Iasonos A, Soslow RA, Leitao MM, Aghajanian C, Hensley ML. O'Cearbhaill R, et al. Among authors: zhou q. Gynecol Oncol. 2010 Mar;116(3):424-9. doi: 10.1016/j.ygyno.2009.10.064. Epub 2009 Nov 24. Gynecol Oncol. 2010. PMID: 19932916 Free PMC article.
The prophylactic conversion to an extended infusion schedule and use of premedication to prevent hypersensitivity reactions in ovarian cancer patients during carboplatin retreatment.
O'Cearbhaill R, Zhou Q, Iasonos A, Hensley ML, Tew WP, Aghajanian C, Spriggs DR, Lichtman SM, Sabbatini PJ. O'Cearbhaill R, et al. Among authors: zhou q. Gynecol Oncol. 2010 Mar;116(3):326-31. doi: 10.1016/j.ygyno.2009.10.070. Epub 2009 Nov 27. Gynecol Oncol. 2010. PMID: 19944454 Free PMC article.
22,106 results
You have reached the last available page of results. Please see the User Guide for more information.